
SubjectWell is a global patient recruitment and commercial solutions company that leverages a robust technology platform, the largest patient network with over 13 million patients, and an extensive partner network to solve challenges in clinical trial patient recruitment. Their SubjectWell+ platform offers comprehensive solutions for patient recruitment and site enablement, paired with advanced commercial capabilities to connect patients with clinical trials and new treatments. They serve sponsors, CROs, sites, site networks, and brand marketers, supporting over 1,400 studies and 8,800 sites across 102 countries and 600+ therapeutic areas. Their services reduce site and patient burden through clinically trained multilingual Patient Companions and various support services, improving enrollment speed and trial retention. SubjectWell aims to transform patient recruitment to reduce the $40 billion losses in clinical trials due to recruitment failures, positioning itself as a leader in patient recruitment and commercial development.

SubjectWell is a global patient recruitment and commercial solutions company that leverages a robust technology platform, the largest patient network with over 13 million patients, and an extensive partner network to solve challenges in clinical trial patient recruitment. Their SubjectWell+ platform offers comprehensive solutions for patient recruitment and site enablement, paired with advanced commercial capabilities to connect patients with clinical trials and new treatments. They serve sponsors, CROs, sites, site networks, and brand marketers, supporting over 1,400 studies and 8,800 sites across 102 countries and 600+ therapeutic areas. Their services reduce site and patient burden through clinically trained multilingual Patient Companions and various support services, improving enrollment speed and trial retention. SubjectWell aims to transform patient recruitment to reduce the $40 billion losses in clinical trials due to recruitment failures, positioning itself as a leader in patient recruitment and commercial development.
Core offering: Global patient recruitment and patient experience platform (SubjectWell+ and OneView)
Scale: 13M+ patient network; supported 1,400+ studies and 8,800+ sites
Founded: 2012
Recent capital events: $35M Series B (Oct 18, 2022); majority growth investment by WindRose (Apr 30, 2024)
Employees (reported): 186
Clinical trial patient recruitment and patient experience
2012
Clinical trial patient recruitment / patient experience
35000000.00
Series B announced Oct 18, 2022 with participation from existing investors and Bertelsmann
Majority growth investment / acquisition by WindRose Health Investors; terms not disclosed
“Backed by growth/strategic investors including Asset Management Ventures, Bertelsmann Investments, and WindRose Health Investors”